Erectile Dysfunction Treatment Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product (Sildenafil (Viagra), Tadalafil (Adcirca, Cialis), Vardenafil (Staxyn, Levitra), Avanafil (Stendra), Others), By Distribution channel (Hospitals, Clinics, and Others) and Region Forecast 2020-2031

Erectile Dysfunction Treatment Market size was valued at US$ 3712.05 million in 2023 and is expected to reach US$ 5951.36 million by 2030, at a CAGR of 7.3% from 2024-2030. The inability to achieve or sustain a firm adequate penile erection during intercourse is referred to as erectile dysfunction. In guys, it is the most frequent sexual health disorder. Stress has an impact on the patient's physical and psychological well-being. Physiological causes such as high blood pressure, high cholesterol, obesity, diabetes, smoking or tobacco use, and psychological ones such as stress, depression, mental health disorders, and so on cause erectile dysfunction. A key element driving the growth of the market for erectile dysfunction treatments is the increase in the number of individuals suffering from erectile dysfunction. Diabetes, renal disease, prostate cancer, high blood pressure, and physical injury to the prostate, penis, and pelvis can all contribute to the condition. Erectile dysfunction can also be caused by emotional and psychological difficulties like sadness, stress, and worry. Prescription pharmaceuticals such as antidepressants, opioid pain relievers, chemotherapeutic agents, hormone therapies, amphetamines, and several sleeping prescriptions might also contribute to this disease.   

Key Developments:

In June 2023, the FDA approved Eroxon, a topical gel containing MED3000, for over-the-counter sale as an ED treatment. Applied directly to the head of the penis before intercourse, the gel utilizes volatile solvents to stimulate nerve endings, increasing blood flow and facilitating erections. Clinical trials have demonstrated that 65% of men using MED3000 achieved an erection within 10 minutes